Literature DB >> 30820610

MLC901 during sleep deprivation rescues fear memory disruption in rats.

Mohammad Nasehi1, Ameneh Mohammadi2, Mohaddeseh Ebrahimi-Ghiri3, Mehrdad Hashemi4, Mohammad-Reza Zarrindast5,6,7.   

Abstract

Several lines of evidence suggest that sleep deprivation disrupts cognitive and emotional abilities and changes the expression of distinctive categories of genes in the brain. In the present study, saline- or MLC901 (a traditional Chinese medicine)-treated male Wistar rats were first submitted to a modified water box (for 24-h sleep deprivation) and then trained in contextual and tone fear conditioning tasks with the purpose to evaluate the effect of MLC901 during sleep deprivation on fear memory retention. Hippocampal mRNA measurement was performed by reverse transcription-polymerase chain reaction (RT-PCR). We found that the exposure of rats to 24 h of sleep deprivation impaired contextual and tone fear memory retention, while administration of MLC901 (0.2, 0.4, and 0.8 mg/kg, once/12 h; i.p.) during sleep deprivation abolished memory deficits. Meanwhile, different doses of MLC901 alone had no effect on performance in both tasks. We observed that MLC901 increased the expression levels of pro-apoptotic BAD, anti-apoptotic Bcl-xL, and Tfam as an index of mitochondrial biogenesis compared to sleep-deprived rats, while MLC901 during sleep deprivation increased BAX, BAD, and Bcl-xL compared to the control group. Sleep deprivation decreased BAX and Tfam, by itself. MLC901 only decreased BAX and Tfam and increased BAD level compared to the non-sleep-deprived control group. It is suggested that MLC901 might be a therapeutic option for memory impairment during sleep deprivation.

Entities:  

Keywords:  Fear memory conditioning; MLC901; Rat; Sleep deprivation

Mesh:

Substances:

Year:  2019        PMID: 30820610     DOI: 10.1007/s00210-018-01612-z

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  28 in total

1.  Impairment of the mitochondrial electron transport chain due to sleep deprivation in mice.

Authors:  Ana C Andreazza; Monica L Andersen; Tathiana A Alvarenga; Marcos R de-Oliveira; Fernanda Armani; Francieli S Ruiz; Larriany Giglio; José C F Moreira; Flávio Kapczinski; Sergio Tufik
Journal:  J Psychiatr Res       Date:  2010-02-21       Impact factor: 4.791

2.  Bcl-2 changes conformation to inhibit Bax oligomerization.

Authors:  Paulina J Dlugosz; Lieven P Billen; Matthew G Annis; Weijia Zhu; Zhi Zhang; Jialing Lin; Brian Leber; David W Andrews
Journal:  EMBO J       Date:  2006-04-27       Impact factor: 11.598

3.  Different Role of CA1 5HT3 Serotonin Receptors on Memory Acquisition Deficit Induced by Total (TSD) and REM Sleep Deprivation (RSD).

Authors:  Zainab Eydipour; Gholamhassan Vaezi; Mohammad Nasehi; Seyed-Ali Haeri-Rouhani; Mohammad-Reza Zarrindast
Journal:  Arch Iran Med       Date:  2017-09       Impact factor: 1.354

Review 4.  The sleep-deprived human brain.

Authors:  Adam J Krause; Eti Ben Simon; Bryce A Mander; Stephanie M Greer; Jared M Saletin; Andrea N Goldstein-Piekarski; Matthew P Walker
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

5.  The effects of MLC901 on tau phosphorylation.

Authors:  Wei Thye Lee; Christopher Chen Li Hsian; Yun-An Lim
Journal:  Neuroreport       Date:  2017-11-08       Impact factor: 1.837

6.  Sleep deprivation impairs spatial memory and decreases extracellular signal-regulated kinase phosphorylation in the hippocampus.

Authors:  Zhiwei Guan; Xuwen Peng; Jidong Fang
Journal:  Brain Res       Date:  2004-08-20       Impact factor: 3.252

7.  Neuroprotective and neuroproliferative activities of NeuroAid (MLC601, MLC901), a Chinese medicine, in vitro and in vivo.

Authors:  C Heurteaux; C Gandin; M Borsotto; C Widmann; F Brau; M Lhuillier; B Onteniente; M Lazdunski
Journal:  Neuropharmacology       Date:  2010-01-11       Impact factor: 5.250

8.  Tetramethylpyrazine reduces cellular inflammatory response following permanent focal cerebral ischemia in rats.

Authors:  Tsung-Kuei Kao; Cheng-Yi Chang; Yen-Chuan Ou; Wen-Ying Chen; Yu-Hsiang Kuan; Hung-Chuan Pan; Su-Lan Liao; Guo-Zhang Li; Chun-Jung Chen
Journal:  Exp Neurol       Date:  2013-04-30       Impact factor: 5.330

9.  Neuroprotection of tanshinone IIA against cerebral ischemia/reperfusion injury through inhibition of macrophage migration inhibitory factor in rats.

Authors:  Yanlin Chen; Xuemei Wu; Shanshan Yu; Xuemei Lin; Jingxian Wu; Lan Li; Jing Zhao; Yong Zhao
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

10.  Ferulic acid attenuates the injury-induced decrease of protein phosphatase 2A subunit B in ischemic brain injury.

Authors:  Phil-Ok Koh
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

View more
  1 in total

1.  Effect of cholestasis and NeuroAid treatment on the expression of Bax, Bcl-2, Pgc-1α and Tfam genes involved in apoptosis and mitochondrial biogenesis in the striatum of male rats.

Authors:  Mohammad Nasehi; Sepehr Torabinejad; Mehrdad Hashemi; Salar Vaseghi; Mohammad-Reza Zarrindast
Journal:  Metab Brain Dis       Date:  2019-11-26       Impact factor: 3.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.